Get started
Author

Irene Della Starza

Observed names: DELLA STARZA I, DELLA STARZA, IRENE, Della Starza I, Della Starza I., Della Starza, I, I Della Starza, I. Della Starza, I.D. S. Della Starza, Irene Della Starza Miss, Irene della Starza
ORCID: 0000-0001-7909-8642
Observed ORCID: 0000-0001-7909-8642
OpenAlex ID: A5069193615
Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances
2019 · Irene Della Starza, Sabina Chiaretti, et al. · Frontiers in Oncology · 124
PDF
Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial
2014 · Sara Galimberti, Stefano Luminari, et al. · Clinical Cancer Research · 119
PDF
Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patients
2014 · Robin Foà, Ilaria Del Giudice, et al. · American Journal of Hematology · 113
PDF
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913
2020 · Sabina Chiaretti, Monica Messina, et al. · Haematologica · 89
PDF
Comparative analysis between RQ‐PCR and digital‐droplet‐PCR of immunoglobulin/T‐cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia
2016 · Irene Della Starza, Vittorio Nunes, et al. · British Journal of Haematology · 69
PDF
Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?
2019 · Ilaria Del Giudice, Sara Raponi, et al. · Frontiers in Oncology · 55
PDF
Up-front blinatumomab improves MRD clearance and outcome in adult Ph– B-lineage ALL: the GIMEMA LAL2317 phase 2 study
2025 · Renato Bassan, Sabina Chiaretti, et al. · Blood · 53
PDF
Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia
2016 · Marilisa Marinelli, Caterina Ilari, et al. · Oncotarget · 50
PDF
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric‐like GIMEMA LAL ‐1308 trial
2020 · Anna Maria Testi, Martina Canichella, et al. · American Journal of Hematology · 45
PDF
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow‐up Samples From Four Prospective Trials of the European MCL Network
2020 · Daniela Drandi, Marion Alcantara, et al. · HemaSphere · 44
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial
2023 · Renato Bassan, Sabina Chiaretti, et al. · Blood Advances · 43
PDF
Comparative analysis between RQ ‐ PCR and digital droplet PCR of BCL 2/ IGH gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma
2017 · Marzia Cavalli, Lucia Anna De Novi, et al. · British Journal of Haematology · 43
Histopathological and molecular features of persistent polyclonal B‐cell lymphocytosis (PPBL) with progressive splenomegaly
2009 · Ilaria Del Giudice, Stefano A. Pileri, et al. · British Journal of Haematology · 43
Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia
2002 · M Mancini, ML Vegna, et al. · Leukemia · 42
Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ ‐ PCR
2014 · Sara Raponi, Irene Della Starza, et al. · British Journal of Haematology · 39
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia
2021 · Irene Della Starza, Vittorio Nunes, et al. · HemaSphere · 35
Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network
2019 · Maria Ilaria Del Principe, Elisa Buzzatti, et al. · Haematologica · 35
PDF
Sequential Chemotherapy and Blinatumomab to Improve Minimal Residual Disease in Adult Ph- B-Lineage Acute Lymphoblastic Leukemia. Final Results of the Phase II Gimema LAL2317 Trial
2023 · Sabina Chiaretti, Irene Della Starza, et al. · Blood · 32
Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia
2023 · Irene Della Starza, Lucia Anna De Novi, et al. · Cancers · 29
PDF
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia
2019 · Irene Della Starza, Lucia Anna De Novi, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 29
Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels
2025 · Riccardo Moia, Donatella Talotta, et al. · Blood Advances · 28
PDF
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations
2020 · Sara Raponi, Caterina Ilari, et al. · British Journal of Haematology · 25
PDF
Identification of monoclonal B-cell lymphocytosis among sibling transplant donors for chronic lymphocytic leukemia patients
2009 · Ilaria Del Giudice, Francesca Romana Mauro, et al. · Blood · 23
Stage I/II follicular lymphoma: spread of bcl‐2/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy
2007 · Alessandro Pulsoni, Irene Della Starza, et al. · British Journal of Haematology · 22
Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy
2019 · Alessandro Pulsoni, Irene Della Starza, et al. · British Journal of Haematology · 21
PDF
Works count: 152
Citation count: 1,660
H-index: 23
I10-index: 43
Year
Topic
Type